133 related articles for article (PubMed ID: 144230)
1. Alterations in dopaminergic receptors in Huntington's disease.
Reisine TD; Fields JZ; Stern LZ; Johnson PC; Bird ED; Yamamura HI
Life Sci; 1977 Oct; 21(8):1123-8. PubMed ID: 144230
[No Abstract] [Full Text] [Related]
2. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
[No Abstract] [Full Text] [Related]
3. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
Klemm N; Murrin LC; Kuhar MJ
Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
[TBL] [Abstract][Full Text] [Related]
4. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
[TBL] [Abstract][Full Text] [Related]
5. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D-1 and D-2 receptors in Huntington's disease.
Cross A; Rossor M
Eur J Pharmacol; 1983 Mar; 88(2-3):223-9. PubMed ID: 6221936
[TBL] [Abstract][Full Text] [Related]
7. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Quik M; Spokes EG; Mackay AV; Bannister R
J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
[TBL] [Abstract][Full Text] [Related]
8. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.
Lee T; Seeman P; Tourtellotte WW; Farley IJ; Hornykeiwicz O
Nature; 1978 Aug; 274(5674):897-900. PubMed ID: 683328
[No Abstract] [Full Text] [Related]
9. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
Near JA; Mahler HR
J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
[No Abstract] [Full Text] [Related]
11. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.
Wong DF; Wagner HN; Pearlson G; Dannals RF; Links JM; Ravert HT; Wilson AA; Suneja S; Bjorvvinssen E; Kuhar MJ
Psychopharmacol Bull; 1985; 21(3):595-8. PubMed ID: 4034877
[No Abstract] [Full Text] [Related]
12. [3H] spiroperidol binding to brain neurotransmitter receptors.
Withy RM; Mayer RJ; Strange PG
FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
[No Abstract] [Full Text] [Related]
13. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
[TBL] [Abstract][Full Text] [Related]
14. Characterization of brain dopaminergic receptors in Huntington's disease.
Reisine TD; Fields JZ; Bird ED; Spokes E; Yamamura HI
Commun Psychopharmacol; 1978; 2(2):79-84. PubMed ID: 149628
[No Abstract] [Full Text] [Related]
15. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
[No Abstract] [Full Text] [Related]
16. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.
Withy RM; Mayer RJ; Strange PG
J Neurochem; 1981 Nov; 37(5):1144-54. PubMed ID: 7299393
[TBL] [Abstract][Full Text] [Related]
17. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
Titeler M
Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
[No Abstract] [Full Text] [Related]
18. A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors.
Varmuza S; Mishra RK
Pharmacol Res Commun; 1981 Jun; 13(6):587-605. PubMed ID: 6170077
[No Abstract] [Full Text] [Related]
19. Huntington's disease and its animal model: alterations in kainic acid binding.
Beaumont K; Maurin Y; Reisine TD; Fields JZ; Spokes E; Bird ED; Yamamura HI
Life Sci; 1979 Feb; 24(9):809-16. PubMed ID: 156298
[No Abstract] [Full Text] [Related]
20. Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
Rosenblatt JE; Shore D; Neckers LM; Perlow MJ; Freed WJ; Wyatt RJ
Eur J Pharmacol; 1979 Dec; 60(4):387-8. PubMed ID: 93551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
